⌘K

Login Start Free

Home/Filings/6-K/0001213900-25-103760

6-K//Foreign company update

NLS Pharmaceutics Ltd. 6-K

Accession 0001213900-25-103760

$NCELCIK 0001783036other

View on SEC.gov Company Profile

Filed

Oct 29, 8:00 PM ET

Accepted

Oct 30, 7:15 AM ET

Size

79.2 KB

Accession

0001213900-25-103760

Documents

3 files

6-K
ea0263090-6k_nlspharma.htmPrimary
REPORT OF FOREIGN PRIVATE ISSUER
EX-99.1
ea026309001ex99-1_nlspharma.htm
PRESS RELEASE TITLED: "NLS PHARMACEUTICS EXPANDS CNS PIPELINE WITH AEX-6XX SERIES DEVELOPED BY AEXON LABS"
GRAPHIC
ex99-1_001.jpg
GRAPHIC

Issuer

NewcelX Ltd.

CIK 0001783036

Entity typeother

IncorporatedSwitzerland

Related Parties

1

filerCIK 0001783036

Filing Metadata

Form type: 6-K
Filed: Oct 29, 8:00 PM ET
Accepted: Oct 30, 7:15 AM ET
Size: 79.2 KB

View on SEC.gov